Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Michael Lanuti, M.D.

Co-Author

This page shows the publications co-authored by Michael Lanuti and Kenneth Tanabe.
Connection Strength

1.614
  1. Peroxidasin Deficiency Re-programs Macrophages Toward Pro-fibrolysis Function and Promotes Collagen Resolution in Liver. Cell Mol Gastroenterol Hepatol. 2022 Jan 28.
    View in: PubMed
    Score: 0.246
  2. Epidermal growth factor receptor inhibition attenuates liver fibrosis and development of hepatocellular carcinoma. Hepatology. 2014 Apr; 59(4):1577-90.
    View in: PubMed
    Score: 0.142
  3. Angiogenesis inhibition using an oncolytic herpes simplex virus expressing endostatin in a murine lung cancer model. Cancer Invest. 2012 Mar; 30(3):243-50.
    View in: PubMed
    Score: 0.124
  4. Oncolytic herpes simplex virus expressing yeast cytosine deaminase: relationship between viral replication, transgene expression, prodrug bioactivation. Cancer Gene Ther. 2012 Mar; 19(3):160-70.
    View in: PubMed
    Score: 0.121
  5. Mouse model of carbon tetrachloride induced liver fibrosis: Histopathological changes and expression of CD133 and epidermal growth factor. BMC Gastroenterol. 2010 Jul 09; 10:79.
    View in: PubMed
    Score: 0.110
  6. Comparison of intravenous versus intraperitoneal administration of oncolytic herpes simplex virus 1 for peritoneal carcinomatosis in mice. Cancer Gene Ther. 2009 Apr; 16(4):291-7.
    View in: PubMed
    Score: 0.098
  7. A functional epidermal growth factor (EGF) polymorphism, EGF serum levels, and esophageal adenocarcinoma risk and outcome. Clin Cancer Res. 2008 May 15; 14(10):3216-22.
    View in: PubMed
    Score: 0.095
  8. Epithelial-to-mesenchymal transition and integrin-linked kinase mediate sensitivity to epidermal growth factor receptor inhibition in human hepatoma cells. Cancer Res. 2008 Apr 01; 68(7):2391-9.
    View in: PubMed
    Score: 0.094
  9. Epidermal growth factor gene functional polymorphism and the risk of hepatocellular carcinoma in patients with cirrhosis. JAMA. 2008 Jan 02; 299(1):53-60.
    View in: PubMed
    Score: 0.093
  10. Fibrotic Response to Neoadjuvant Therapy Predicts Survival in Pancreatic Cancer and Is Measurable with Collagen-Targeted Molecular MRI. Clin Cancer Res. 2020 09 15; 26(18):5007-5018.
    View in: PubMed
    Score: 0.055
  11. Epigallocatechin Gallate Induces Hepatic Stellate Cell Senescence and Attenuates Development of Hepatocellular Carcinoma. Cancer Prev Res (Phila). 2020 06; 13(6):497-508.
    View in: PubMed
    Score: 0.054
  12. The farnesoid X receptor agonist EDP-305 reduces interstitial renal fibrosis in a mouse model of unilateral ureteral obstruction. FASEB J. 2019 06; 33(6):7103-7112.
    View in: PubMed
    Score: 0.050
  13. Pioglitazone Reduces Hepatocellular Carcinoma Development in Two Rodent Models of Cirrhosis. J Gastrointest Surg. 2019 01; 23(1):101-111.
    View in: PubMed
    Score: 0.049
  14. Orthotopic and heterotopic murine models of pancreatic cancer and their different responses to FOLFIRINOX chemotherapy. Dis Model Mech. 2018 07 30; 11(7).
    View in: PubMed
    Score: 0.048
  15. Molecular imaging of oxidized collagen quantifies pulmonary and hepatic fibrogenesis. JCI Insight. 2017 Jun 02; 2(11).
    View in: PubMed
    Score: 0.045
  16. Molecular Liver Cancer Prevention in Cirrhosis by Organ Transcriptome Analysis and Lysophosphatidic Acid Pathway Inhibition. Cancer Cell. 2016 Dec 12; 30(6):879-890.
    View in: PubMed
    Score: 0.043
  17. Metformin prevents hepatocellular carcinoma development by suppressing hepatic progenitor cell activation in a rat model of cirrhosis. Cancer. 2016 Apr 15; 122(8):1216-27.
    View in: PubMed
    Score: 0.041
  18. Molecular subclasses of hepatocellular carcinoma predict sensitivity to fibroblast growth factor receptor inhibition. Int J Cancer. 2016 Mar 15; 138(6):1494-505.
    View in: PubMed
    Score: 0.040
  19. Assessment of Proliferation and Cytotoxicity in a Biomimetic Three-Dimensional Model of Lung Cancer. Ann Thorac Surg. 2015 Aug; 100(2):414-21.
    View in: PubMed
    Score: 0.039
  20. Epidermal growth factor A61G gene polymorphism, gastroesophageal reflux disease and esophageal adenocarcinoma risk. Carcinogenesis. 2009 Aug; 30(8):1363-7.
    View in: PubMed
    Score: 0.026
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.